← Leaderboards
Dana Giulian
Baylor College Of Medicine
$13,949,035
Attributed
$13,949,035
Total exposure
11
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.9M · FY2005–09$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$13,949,035 · 11
By mechanism
R01$7,962,684 · 6
R42$5,817,079 · 2
M01$89,647 · 2
P50$79,625 · 1
Top collaborators
No co-investigators on record.
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Luis Vicente Colom$9,409,255
- Baruch A Brody$1,030,750
- William Thomas Shearer$34,592,326
- Arthur L. Beaudet$51,053,980
- Hui Zheng$41,943,035
Others in their field
Top investigators on “Microglia”
- Keri Hammel · The Emmes Company, Llc$53,700,408
- Susan Abushakra · Alzheon, Inc.$47,690,244
- Li-Huei Tsai · Massachusetts Institute Of Technology$36,819,768
- Philip L De Jager · Columbia University Health Sciences$32,795,139
- Shilpa J Buch · University Of Kansas Medical Center$25,300,887
- Supriya Menezes · The Emmes Company, Llc$25,277,032
Research focus
MicrogliaNeurotoxinsTissue /Cell CultureLaboratory RatAmyloid ProteinsAlzheimer'S DiseaseNeuritic PlaquesCerebrospinal FluidReceptor BindingNmda ReceptorsBiomarkerTechnology /Technique DevelopmentCognitionSynapsesNeuronsHuman TissueGenetically Modified AnimalsGliosisNeocortexBrainAids Dementia ComplexInflammationPolymerase Chain ReactionChemical Structure Function
Grant awards (33)
Study of Novel Brain Toxin Associated With HIV Dementia$530,829
R01 · FY2009 · MH · contact PI
Study of Novel Brain Toxin Associated With HIV Dementia$517,910
R01 · FY2008 · MH · contact PI
Study of Novel Brain Toxin Associated With HIV Dementia$520,461
R01 · FY2007 · MH · contact PI
Novel CSF biomarker to predict impaired cognition in HIV$1,032,541
R42 · FY2006 · NS · contact PI
Development of a transgenic rat to study brain aging$713,574
R42 · FY2006 · AG · contact PI
Study of Novel Brain Toxin Associated With HIV Dementia$521,049
R01 · FY2006 · MH · contact PI
DRUG TREATMENT OF BRAIN INFLAMMATION IN ALZHEIMER'S DISEASE$17,059
M01 · FY2006 · RR · contact PI
Novel CSF biomarker to predict impaired cognition in HIV$1,005,479
R42 · FY2005 · NS
Development of a transgenic rat to study brain aging$895,834
R42 · FY2005 · AG
Study of Novel Brain Toxin Associated With HIV Dementia$518,046
R01 · FY2005 · MH
Novel CSF biomarker to predict impaired cognition in HIV$448,845
R42 · FY2005 · NS
DRUG TREATMENT OF BRAIN INFLAMMATION IN ALZHEIMER'S DISEASE$68,329
M01 · FY2005 · RR
Drug inhibition of beta-amyloid-Induced Immune Responses$726,185
R01 · FY2004 · AG
Novel CSF biomarker to predict impaired cognition in HIV$586,905
R42 · FY2004 · NS
Novel CSF biomarker to predict impaired cognition in HIV$585,090
R42 · FY2004 · NS
Drug Treatment of Brain Inflammation in Alzheimer's Disease$4,259
M01 · FY2004 · RR
Development of a transgenic rat to study brain aging$548,811
R42 · FY2003 · AG
Drug inhibition of beta-amyloid-Induced Immune Responses$531,757
R01 · FY2003 · AG
SCAVENGER RECEPTORS AND CNS$309,313
R01 · FY2003 · NS
Drug inhibition of beta-amyloid-Induced Immune Responses$258,058
R01 · FY2003 · AG
GLIA-MEDIATED BRAIN INJURY IN ALZHEIMER'S DISEASE$110,768
R01 · FY2003 · AG
GLIA-MEDIATED BRAIN INJURY IN ALZHEIMER'S DISEASE$342,580
R01 · FY2002 · AG
SCAVENGER RECEPTORS AND CNS$300,304
R01 · FY2002 · NS
IMMUNOPATHOLOGY OF NEURON INJURY IN ALZHEIMER'S DISEASE$261,625
R01 · FY2002 · NS
Drug inhibition of beta-amyloid-Induced Immune Responses$531,757
R01 · FY2001 · AG
GLIA-MEDIATED BRAIN INJURY IN ALZHEIMER'S DISEASE$334,632
R01 · FY2001 · AG
SCAVENGER RECEPTORS AND CNS$291,560
R01 · FY2001 · NS
IMMUNOPATHOLOGY OF NEURON INJURY IN ALZHEIMER'S DISEASE$261,625
R01 · FY2001 · NS
GLIA-MEDIATED BRAIN INJURY IN ALZHEIMER'S DISEASE$326,442
R01 · FY2000 · AG
SCAVENGER RECEPTORS AND CNS$283,069
R01 · FY2000 · NS
IMMUNOPATHOLOGY OF NEURON INJURY IN ALZHEIMER'S DISEASE$261,625
R01 · FY2000 · NS
SUPPRESSING PLAQUE ACTIVATION OF MICROGLIA IN ALZHEIMERS$223,089
R01 · FY2000 · NS
NEUROIMMUNE REGULATION IN ALZHEIMERS DISEASE$79,625
P50 · FY2000 · AG